Kestra Private Wealth Services’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Kestra Private Wealth Services’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,003	Closed	-$13K	–	1073
2021 Q4	$13K	Buy	+1,003	New	+$16.6K	﹤0.01%	984
2021 Q3	–	Sell	-1,536	Closed	-$67K	–	980
2021 Q2	$67K	Sell	1,536 -73	-5%	-$4.07K	﹤0.01%	868
2021 Q1	$117K	Buy	+1,609	New	+$114K	0.01%	768

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Kestra Private Wealth Services's ORTX Position: Q1 2022 in Review

Kestra Private Wealth Services sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2022, closing a stake of 1,003 shares — an estimated $13K sold.

Kestra Private Wealth Services first reported a position in ORTX in Q1 2021 and held it in 3 quarters. The position peaked at $117K in Q1 2021. 61 funds tracked by Wall St. Rank hold ORTX as of Q1 2022.

Kestra Private Wealth Services reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Kestra Private Wealth Services sold 1,003 Orchard Therapeutics plc American Depositary Shares shares in Q1 2022, an estimated $13K.
Kestra Private Wealth Services first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2021 and held it in 3 quarters.
Kestra Private Wealth Services's Orchard Therapeutics plc American Depositary Shares position peaked at $117K in Q1 2021.
61 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2022.

Based on Kestra Private Wealth Services's 13F filing for Q1 2022, filed 26 May 2022.